The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 385.50
Bid: 384.50
Ask: 385.50
Change: -1.00 (-0.26%)
Spread: 1.00 (0.26%)
Open: 389.00
High: 389.00
Low: 383.50
Prev. Close: 386.50
CHG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NGCD NOTIFICATION

5 Sep 2018 07:00

RNS Number : 7740Z
Chemring Group PLC
05 September 2018

FOR IMMEDIATE RELEASE 5 SEPTEMBER 2018

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

NGCD NOTIFICATION

Chemring is pleased to announce that its US based subsidiary, Chemring Sensors and Electronic Systems (CSES), has been notified that it has been down selected as one of the suppliers on the first stream of the Next Generation Chemical Detector (NGCD1). NGCD1, now known as the Aerosol & Vapour Chemical Agent Detector (AVCAD), is the long-term Program of Record for the US Department of Defense to detect traditional and advanced threat vapours, and liquid and solid aerosols.

The resultant contract award, which is expected to be received in the coming months, is expected to take the form of an indefinite delivery, indefinite quantity (IDIQ) contract and will be for the Engineering and Manufacturing Development of the program, together with options for varying quantities of hardware under Low Rate Initial Production and Full Rate Production phases of the program.

Michael Ord, Group Chief Executive of Chemring, commented:

"As the largest stream under the NGCD Program of Record, the AVCAD award decision is a significant development for Chemring and is the culmination of a number of years of research and development activity. We are delighted to have been chosen on this long-term program."

-ENDS-

For further information:

Rupert Pittman Group Director of Corporate Affairs, 01794 833901

Chemring Group PLC

Andrew Jaques MHP Communications 020 3128 8100

James White

Notes to editors

Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

Employing approximately 2,600 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

Chemring is organised under three strategic product segments: Countermeasures, Sensors, and Energetics

Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

www.chemring.co.uk

Cautionary statements

This announcement contains unaudited information based on management accounts and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

No statement in this announcement is intended as a profit forecast for FY18 and no statement in this announcement should be interpreted to mean that underlying operating profit for the current or future financial years would necessarily be above a minimum level, or match or exceed the historical published underlying operating profit or set a minimum level of underlying operating profit.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
CNTFZLLBVKFZBBZ
Date   Source Headline
11th Jun 201510:02 amRNSAdditional Listing
2nd Jun 20157:00 amRNSTotal Voting Rights
1st May 201512:01 pmRNSTotal Voting Rights
10th Apr 201511:59 amRNSTotal Voting Rights
19th Mar 20152:21 pmRNSResult of AGM
19th Mar 20157:00 amRNSAGM Statement
2nd Mar 20151:41 pmRNSTotal Voting Rights
2nd Feb 20151:16 pmRNSTotal Voting Rights
27th Jan 20154:10 pmRNSDirector/PDMR Shareholding
27th Jan 20154:09 pmRNSDirector/PDMR Shareholding
27th Jan 20154:08 pmRNSDirector/PDMR Shareholding
27th Jan 201512:25 pmRNSDirector/PDMR Shareholding
27th Jan 201512:11 pmRNSDirector/PDMR Shareholding
27th Jan 201512:08 pmRNSDirector/PDMR Shareholding
27th Jan 201512:03 pmRNSDirector/PDMR Shareholding
23rd Jan 20154:33 pmRNSDirector Declaration
22nd Jan 20157:00 amRNSFULL YEAR RESULTS
2nd Jan 201512:59 pmRNSTotal Voting Rights
30th Dec 20147:00 amRNSDirectorate Change
19th Dec 201410:26 amRNSBlocklisting Interim Review
1st Dec 20141:26 pmRNSHolding(s) in Company
1st Dec 20141:22 pmRNSTotal Voting Rights
25th Nov 20147:00 amRNSPOST-CLOSE STATEMENT
3rd Nov 20142:36 pmRNSTotal Voting Rights
1st Oct 201410:04 amRNSTotal Voting Rights
17th Sep 20147:00 amRNSInterim Management Statement
1st Sep 20142:52 pmRNSTotal Voting Rights
8th Aug 201412:28 pmRNSDirector/PDMR Shareholding
1st Aug 201410:34 amRNSTotal Voting Rights
21st Jul 201410:03 amRNSDirector/PDMR Shareholding
9th Jul 201411:57 amRNSDirector/PDMR Shareholding
2nd Jul 20147:30 amRNSHolding(s) in Company
1st Jul 201412:10 pmRNSDirector/PDMR Shareholding
1st Jul 20149:38 amRNSHolding(s) in Company
1st Jul 20149:00 amRNSChange of Registered Office
24th Jun 20147:00 amRNSDirectorate Change
24th Jun 20147:00 amRNSHalf Yearly Report
18th Jun 201411:00 amRNSBlocklisting Interim Review
30th May 20144:59 pmRNSTotal Voting Rights
27th May 20143:29 pmRNSHolding(s) in Company
27th May 20142:37 pmRNSCompletion of Disposal of European Munitions
22nd May 20147:00 amRNSUpdate on Disposal
12th May 20149:40 amRNSResult of EGM
9th May 20147:00 amRNSACQUISITION OF 3D-RADAR
1st May 201412:18 pmRNSTotal Voting Rights
30th Apr 201411:34 amRNSDirector/PDMR Shareholding
29th Apr 20141:20 pmRNSDirector/PDMR Shareholding
29th Apr 201412:42 pmRNSPDMR Shareholding
29th Apr 201411:59 amRNSDirector/PDMR Shareholding
29th Apr 201411:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.